Vials and Ampoules Market: Current Analysis and Forecast (2022-2028)

The vials and ampoules market is anticipated to grow at a CAGR of 8% during the forecast period (2022-2028). The growing pharmaceutical sector, rising healthcare costs, and expanding geographical presence of vial and ampoules manufacturers are some of the drivers driving the market's growth.

Furthermore, the rising spending on healthcare in developing countries, such as India and China, is also contributing to the growth to the market. For instance, as per the IBEF, India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the U.S. and 25% of all medicine in the U.K.

Thus, as developing nations across the world focuses on offering world class manufacturing excellence, robust infrastructure, cost-competitiveness, the market for vials and ampoules is expected to witness significant growth during the forecast period across end-use industries.

The key players with a considerable market share in the global market include Schott AG, Gerresheimer AG, SGD SA, Nuova Ompi SRL (Stevanato Group), NIPRO Corporation, Piramida d.o.o., Corning Incorporated, Crestani srl, Pacific Vials Manufacturing Inc., and Borosil Ltd.

Insights Presented in the Report:

"Amongst product, vials held a prominent share in the market in 2020"

Based on product, the market is categorized into vials and ampoules. In 2020, vials category accounted for a significant share in the market. This can be majorly attributed to the growing demand for packaging containers, such as vials, among pharmaceutical and biotech companies around the world. Furthermore, growing geriatric population and age-related ailments has increased the demand for high-quality drugs, including biologics,, which is further fueling the growth in market.

"Amongst end-use, pharmaceutical to retain its dominance during the forecast period"

Based on end-use, the market is categorized into pharmaceutical, food & beverage, chemical, and personal care & cosmetics. In 2020, pharmaceutical end-use industry accounted for majority share in the market. Vials and ampoules can be extensively seen on the shelves of chemistry-based or pharmaceutical laboratories. Both types of vessels are essential for the preservation and storage of liquids, pharmaceutical fluids, capsules, and other similar contents, usually for pharmaceutical uses. Furthermore, stringent regulations related to storing vaccines and other pharmaceuticals is further expected to drive the market.

"Amongst material, glass category to witness significant growth during 2022-2028"

Based on material, the market is categorized into glass and plastic. The glass segment dominated the market in 2020. Glass is the most extensively used material for the manufacturing of vials and ampoules owing to its properties such as being inert and reusable. Due to its inert nature, it can store highly corrosive and chemically unstable compounds. Moreover, glass can store products for the long term compared to plastics. It is also approved by FDA as GRAS.

"Asia-Pacific is expected to retain its position during the forecast period"

For a understanding of the market adoption of vials and ampoules, the market is analyzed based on its worldwide presence in the countries such as North America (the United States, Canada, Rest of North America), Europe (Germany, the United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and Rest of World. The large and growing base of end-use industries of the Asia-Pacific region along with the presence of international and local manufacturers are two of the key attributable factors for the growth of the market. Furthermore, growing various government initiatives and support for the development of the healthcare and pharmaceutical industry in the region is fueling market growth. According to India Brand Equity Foundation (IBEF), India is the largest provider of generic medicines in the world. India stood at 3rd position in terms of pharmaceutical production by volume. The country supply more than 50% of the global demand for various vaccines, 25% of all medicines in the U.K., and 40% generic medicines in the U.S.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive country-level analysis of the industry

Customization Options:

The global vials and ampoules market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.